Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Clinical Trials > Long-Acting Beta Agonist Step Down Study (LASST)
Jumbo Large Regular Text:
Print
Clinical Trials

Long-Acting Beta Agonist Step Down Study (LASST)

Related Content

Health Articles

  • Understanding Clinical Trials: A participants' guide

In This Section

Related Clinical Trials

  • Asthma and Allergies
  • Children's Health
  • Children's Primary Care
  • Duke Medicine
  • Duke Primary Care
  • Family Medicine
  • Internal Medicine
  • Men's Health
  • Primary Care Services
  • Pulmonology and Respiratory Medicine
  • Research
  • Women's Health

Share

Males and females, age 12 years and older are needed to participate in a research study to evaluate the optimal treatment strategy for reducing therapy in people with asthma.

Eligibility Requirements
Eligible participants must be non-smokers, have well controlled asthma and be taking an inhaler with a long-acting bronchodilator and corticosteroid.

Study Requirements
Study requires 11 clinic visits and one phone visit.

Compensation
Participants will receive asthma medications and compensation for each visit.

For more information, call 919-613-6246 or email dcrurecruit@duke.edu (Please use reference number 34544).


(REF# Pro00034544)
Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En EspaƱol | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: July 11, 2012
Published: July 11, 2012
URL: http://www.dukehealth.org/clinicaltrials/20120711092111315